Article Details
Retrieved on: 2021-02-08 21:56:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Under terms of the agreement, Coherus will receive U.S. and Canadian rights to Junshi's anti-PD-1 antibody toripalimab. Monoclonal antibodies that ...
Article found on: www.gurufocus.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here